Cours BioLargo, Inc. OTC Bulletin Board
Actions
US09065A1007
Produits chimiques de base
Cours en clôture
Autres places de cotation
|
||
- USD | - |
14/05 | Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
02/04 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 |
CA 2024 * | 19,05 M 17,3 M | CA 2025 * | 25,76 M 23,41 M | Capitalisation | 93,98 M 85,38 M |
---|---|---|---|---|---|
Résultat net 2024 * | -1 M -909 k | Résultat net 2025 * | - 0 | VE / CA 2024 * | 4,93 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 3,65 x |
PER 2024 * |
-31,8
x | PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 85,77% |
Dernier transcript sur BioLargo, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/06/02 |
Charles Dargan
DFI | Director of Finance/CFO | 68 | 01/02/08 |
Chief Operating Officer | 55 | 01/06/02 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 28/04/06 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/04/07 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/06/02 |
Varia. 1 janv. | Capi. | |
---|---|---|
+5,41% | 105 Md | |
-3,11% | 64,71 Md | |
+73,33% | 49,72 Md | |
+17,24% | 38,6 Md | |
+6,13% | 32,54 Md | |
+12,77% | 19,94 Md | |
+15,03% | 16,92 Md | |
+19,06% | 15,2 Md | |
+6,28% | 14,39 Md |
- Bourse
- Actions
- Action BLGO
- Action